D-0163-2017 Class II Terminated

Recalled by Ascend Laboratories LLC — Montvale, NJ

FDA drug recall D-0163-2017 was initiated by Ascend Laboratories LLC on Nov 2, 2016 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP The recall status is terminated (terminated Jun 7, 2017). Affected quantity: 1739 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 7, 2016
Initiation Date
Nov 2, 2016
Termination Date
Jun 7, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1739 bottles

Product description

Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Montvale, NJ NDC 67877-217-10

Reason for recall

Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP

Distribution pattern

AL, FL, GA, SC & TN

Code information

Lot 6121056, exp 5/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0163-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0163-2017. Report a data issue: hello@regdatalab.com.